Drug Profile

Biological isolate - United Paragon Associates

Alternative Names: Fertilized egg extract - United Paragon Associates; Rellidep

Latest Information Update: 27 Feb 2016

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator United Paragon Associates
Class Antidepressants; Stem cell therapies
Mechanism of Action Glutamate receptor modulators; Neurokinin 2 receptor modulators

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes
Available For Licensing Yes - Major depressive disorder

Highest Development Phases

No development reported Major depressive disorder

Most Recent Events

26 Feb 2016 No development reported - Phase-II/III for Major depressive disorder in Canada (PO)
17 Dec 2013 Biological isolate - United Paragon Associates is available for licensing as of 17 Dec 2013.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com